Literature DB >> 1886774

Stringent integrity requirements for both trans-activation and DNA-binding in a trans-activator, Oct3.

M Imagawa1, A Miyamoto, M Shirakawa, H Hamada, M Muramatsu.   

Abstract

POU-specific and POU-homeo domains of Oct3 were produced in Echerichia coli for characterization of DNA binding to the octamer sequence. POU domain protein including A, B and H domains could bind to the octamer sequence efficiently and specifically, and DNase I footprint analysis gave an indistinguishable protection pattern between recombinant POU protein of Oct3 and native Oct3 from undifferentiated P19 cells. Truncated mutants, which contained B-specific and H domains or the H domain only, showed no binding activity, indicating that both of POU-specific and POU-homeo domains are essential for binding activity to octamer sequence. Furthermore, a 6 amino acid deletion from the N-terminal region of the A-specific domain is enough to destroy the binding activity. As for trans-activation, the N-terminal region is essential and sufficient. Deletion of the N-terminal proline-rich region rapidly eliminated trans-activating activity. These data strongly indicate the stringent integrity requirements for both trans-activation and DNA-binding domains in Oct3.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1886774      PMCID: PMC328641          DOI: 10.1093/nar/19.16.4503

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  Oct-3 is a maternal factor required for the first mouse embryonic division.

Authors:  M H Rosner; R J De Santo; H Arnheiter; L M Staudt
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

2.  Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP.

Authors:  M Imagawa; R Chiu; M Karin
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

3.  Silencer binding proteins function on multiple cis-elements in the glutathione transferase P gene.

Authors:  M Imagawa; S Osada; A Okuda; M Muramatsu
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

4.  The oct-1 homeo domain contacts only part of the octamer sequence and full oct-1 DNA-binding activity requires the POU-specific domain.

Authors:  C P Verrijzer; A J Kal; P C van der Vliet
Journal:  Genes Dev       Date:  1990-11       Impact factor: 11.361

Review 5.  The structure of the homeodomain and its functional implications.

Authors:  W J Gehring; M Müller; M Affolter; A Percival-Smith; M Billeter; Y Q Qian; G Otting; K Wüthrich
Journal:  Trends Genet       Date:  1990-10       Impact factor: 11.639

6.  LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein.

Authors:  P Descombes; M Chojkier; S Lichtsteiner; E Falvey; U Schibler
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

7.  The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions.

Authors:  H A Ingraham; S E Flynn; J W Voss; V R Albert; M S Kapiloff; L Wilson; M G Rosenfeld
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

8.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

9.  Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements.

Authors:  M Miyamoto; T Fujita; Y Kimura; M Maruyama; H Harada; Y Sudo; T Miyata; T Taniguchi
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

10.  Oct-6: a POU transcription factor expressed in embryonal stem cells and in the developing brain.

Authors:  N Suzuki; H Rohdewohld; T Neuman; P Gruss; H R Schöler
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

View more
  14 in total

1.  Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells.

Authors:  Hitoshi Niwa; Shinji Masui; Ian Chambers; Austin G Smith; Jun-ichi Miyazaki
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

2.  Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.

Authors:  D C Ambrosetti; C Basilico; L Dailey
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Mapping the transactivation domain of the Oct-6 POU transcription factor.

Authors:  D Meijer; A Graus; G Grosveld
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

4.  Solubility partner IF2 Domain I enables high yield synthesis of transducible transcription factors in Escherichia coli.

Authors:  William C Yang; John P Welsh; Jieun Lee; John P Cooke; James R Swartz
Journal:  Protein Expr Purif       Date:  2011-07-02       Impact factor: 1.650

5.  Reversal of Xenopus Oct25 function by disruption of the POU domain structure.

Authors:  Ying Cao; Franz Oswald; Stephan A Wacker; Karin Bundschu; Walter Knöchel
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

6.  Oct3/4-associating proteins from embryonal carcinoma and spermatogenic cells of mouse.

Authors:  A Tomilin; V Vorob'ev; M Drosdowsky; G E Séralini
Journal:  Mol Biol Rep       Date:  1998-03       Impact factor: 2.316

7.  A novel genetic system to isolate a dominant negative effector on DNA-binding activity of Oct-2.

Authors:  A Terunuma; K Shiba; T Noda
Journal:  Nucleic Acids Res       Date:  1997-05-15       Impact factor: 16.971

8.  The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain.

Authors:  A Brehm; K Ohbo; H Schöler
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

9.  Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site.

Authors:  E Ben-Shushan; J R Thompson; L J Gudas; Y Bergman
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

10.  Structure of the Oct-3 POU-homeodomain in solution, as determined by triple resonance heteronuclear multidimensional NMR spectroscopy.

Authors:  E H Morita; M Shirakawa; F Hayashi; M Imagawa; Y Kyogoku
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.